Prednisone News and Research

RSS

Cause of effectiveness discovered for a cirrhosis treatment useful in 40 percent of patients

Scientists of the Center for Applied Medical Research (CIMA) of the University of Navarra have discovered the molecular mechanism responsible for the effectiveness of an existing treatment for primary biliary cirrhosis, which combines two substances in order to produce an effect that does not result from either substance separately.

28 Feb 2008

New discoveries on what does and doesn't affect immune system

Scientists know that a number of factors can affect the body's immune system: poor diet, certain steroids, chronic stress. Now researchers at Michigan State University have discovered that an appetite-controlling hormone also affects the immune system, while natural versions of certain steroids do not.

4 Feb 2008

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report funded by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services.

18 Dec 2007

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center, which is sponsored by the Agency for Healthcare Research and Quality.

19 Nov 2007

Head-to-head comparison of Forteo and Fosamax

The osteoporosis drug Forteo works better than Fosamax to strengthen bones in arthritis patients with prednisone-induced osteoporosis, according to a new study from a researcher at the University of Alabama at Birmingham (UAB.)

15 Nov 2007

Mycophenolate mofetil therapy effective for reducing lupus flares

Mayo Clinic researchers have shown that an immunosuppressive drug used in organ transplant cases is effective in reducing flare-ups in patients with systemic lupus erythematosus (SLE)

13 Nov 2007

Mayo Clinic clarifies diagnosis for primary central nervous system vasculitis (PCNSV)

Mayo Clinic has clarified the methods of diagnosis and optimal management of a rare and little-understood blood vessel disease of the brain and spinal cord that often leads to stroke or death.

19 Oct 2007

Self-management education for patients with chronic obstructive pulmonary disease

Self-management education programs for people with chronic obstructive pulmonary disorder (COPD) significantly decrease hospital admissions, researchers report in a new systematic review of studies.

17 Oct 2007

Thalidomide therapy helps elderly myeloma patients live longer

The drug thalidomide is making a comeback as a cancer fighting therapy and has been successfully used along with standard therapy to treat the blood cancer myeloma.

7 Oct 2007

Biologic treatment for rheumatoid arthritis and the risk of cancer

The relationship between rheumatoid arthritis (RA), an autoimmune disease marked by chronic inflammation of the joints and tissue surrounding vital organs, and the incidence of cancer is complicated.

30 Aug 2007

Chemotherapy and blood stem cell transplantation results in long-term survival for amyloidosis patients

Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that high-dose chemotherapy and blood stem cell transplantation can result in long-term survival for patients diagnosed with primary systemic light chain (AL) Amyloidosis.

8 Aug 2007

FDA advisory committee recommends that FDA wait for overall survival results from Satraplatin phase 3 trial

GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.

25 Jul 2007

Study shows improvement of rheumatoid arthritis during pregnancy

Disease activity in patients with rheumatoid arthritis (RA) is significantly reduced during pregnancy, according to new data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.

17 Jun 2007

Adding radioimmunotherapy to chemo may help patients with lymphoma

Patients treated for follicular lymphoma, a slow-growing type of non-Hodgkin's lymphoma, may benefit from chemotherapy followed by radioimmunotherapy, according to a University of Pittsburgh Medical Center (UPMC) study presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago and published as Abstract 8005 in the ASCO proceedings.

5 Jun 2007

FDA approves Norditropin for short stature in children with Noonan syndrome

Novo Nordisk has announced that Norditropin (somatropin[rDNA origin] injection) received U.S. Food and Drug Administration (FDA) approval for the treatment of short stature in children with Noonan syndrome.

3 Jun 2007

Methods for treating lupus nephritis

Good patient information is essential for choosing the best treatment for the kidney disease lupus nephritis.

17 May 2007

Honey for diabetic ulcers

The sore on Catrina Hurlburt's leg simply wouldn't heal. Complications from a 2002 car accident left Hurlburt, a borderline diabetic, with recurring cellulitis and staph infections.

4 May 2007

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

Evaluation of antibody responses in patients with advanced prostate cancer from these studies shows that the GVAX cell-based immunotherapy induces antibody responses to a broad array of prostate cancer- associated antigens, including some not previously known to be associated with prostate cancer.

18 Apr 2007

FDA accepts GPC Biotech's Satraplatin NDA

GPC Biotech AG has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for satraplatin in combination with prednisone for patients with hormone-refractory prostate cancer (HRPC) whose prior chemotherapy has failed.

17 Apr 2007

Using a light hand to treat Hodgkin disease

Children with low-risk Hodgkin disease can be cured using cancer drugs that have only minimal or no toxicity, combined with low doses of radiation, according to St. Jude researchers.

13 Mar 2007

Prednisone News and Research

Cause of effectiveness discovered for a cirrhosis treatment useful in 40 percent of patients

New discoveries on what does and doesn't affect immune system

Combining medications often best strategy to battle rheumatoid arthritis

Combining medications often best strategy to battle rheumatoid arthritis

Head-to-head comparison of Forteo and Fosamax

Mycophenolate mofetil therapy effective for reducing lupus flares

Mayo Clinic clarifies diagnosis for primary central nervous system vasculitis (PCNSV)

Self-management education for patients with chronic obstructive pulmonary disease

Thalidomide therapy helps elderly myeloma patients live longer

Biologic treatment for rheumatoid arthritis and the risk of cancer

Chemotherapy and blood stem cell transplantation results in long-term survival for amyloidosis patients

FDA advisory committee recommends that FDA wait for overall survival results from Satraplatin phase 3 trial

Study shows improvement of rheumatoid arthritis during pregnancy

Adding radioimmunotherapy to chemo may help patients with lymphoma

FDA approves Norditropin for short stature in children with Noonan syndrome

Methods for treating lupus nephritis

Honey for diabetic ulcers

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

FDA accepts GPC Biotech's Satraplatin NDA

Using a light hand to treat Hodgkin disease

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

Revolutionizing Schizophrenia Research

Latest News